Primary |
Drug Use For Unknown Indication |
50.0% |
Hypertension |
50.0% |
|
Upper Limb Fracture |
100.0% |
|
Secondary |
Hypertension |
39.7% |
Product Used For Unknown Indication |
22.1% |
Drug Exposure During Pregnancy |
8.8% |
Hypercholesterolaemia |
8.8% |
Crohn's Disease |
7.4% |
Type 2 Diabetes Mellitus |
4.4% |
Blood Glucose Increased |
2.9% |
Influenza Like Illness |
2.9% |
Prostate Cancer Metastatic |
2.9% |
|
Transaminases Increased |
15.2% |
Rhabdomyolysis |
12.1% |
Aortic Valve Disease |
6.1% |
Congenital Central Nervous System Anomaly |
6.1% |
Malaise |
6.1% |
Pemphigoid |
6.1% |
Renal Failure Acute |
6.1% |
Urticaria |
6.1% |
Depressed Mood |
3.0% |
Drug Exposure During Pregnancy |
3.0% |
Dyspnoea |
3.0% |
Eosinophilia |
3.0% |
Hypokalaemia |
3.0% |
Hypotension |
3.0% |
Interstitial Lung Disease |
3.0% |
Neonatal Respiratory Acidosis |
3.0% |
Orthostatic Hypotension |
3.0% |
Paralysis |
3.0% |
Prothrombin Level Decreased |
3.0% |
Rales |
3.0% |
|
Concomitant |
Hypertension |
23.6% |
Product Used For Unknown Indication |
19.1% |
Drug Use For Unknown Indication |
16.1% |
Type 2 Diabetes Mellitus |
4.3% |
Prophylaxis |
4.1% |
Rheumatoid Arthritis |
4.1% |
Diabetes Mellitus |
3.1% |
Atrial Fibrillation |
2.9% |
Breast Cancer |
2.7% |
Anaesthesia |
2.5% |
Colon Cancer |
2.1% |
Hiv Infection |
2.1% |
Premedication |
1.9% |
Gastric Cancer |
1.7% |
Hypercholesterolaemia |
1.7% |
Osteoporosis |
1.7% |
Erysipelas |
1.5% |
Hepatic Cancer |
1.5% |
Hypothyroidism |
1.5% |
Pain |
1.5% |
|
Vomiting |
14.9% |
Renal Failure Acute |
9.5% |
Thrombocytopenia |
6.8% |
Myocardial Infarction |
5.4% |
Oesophagitis |
5.4% |
Phlebitis |
5.4% |
Renal Disorder |
5.4% |
Renal Failure |
5.4% |
Somnolence |
5.4% |
Subdural Haematoma |
5.4% |
Acute Generalised Exanthematous Pustulosis |
4.1% |
Drug Rash With Eosinophilia And Systemic Symptoms |
4.1% |
Hypersensitivity |
4.1% |
Anaemia |
2.7% |
Basal Cell Carcinoma |
2.7% |
Breast Cancer Metastatic |
2.7% |
Cardiac Failure Congestive |
2.7% |
Cardio-respiratory Arrest |
2.7% |
General Physical Health Deterioration |
2.7% |
Hallucination |
2.7% |
|